A Proteolytic Product of Histone H2A As a Marker for Cancer
The present invention relates to proteolytic products of histone H2A. In particular, the present invention discloses a peptide having the amino acid sequence VTIAQGGVLPNIQAV which can be used to determine cleavage of histone H2A. More in particular, the present invention relates to the latter peptide as a marker to diagnose or to determine prognosis of cancer such as chronic lymphocytic leukemia.
WO 2,011,029,946 [MORE INFO
DHAENENS MAARTEN [BE]; DEFORCE DIETER [BE]
Type of Offer:
« More Biotech Patents